Cargando…

Central venous-to-arterial CO(2) difference is a poor tool to predict adverse outcomes after cardiac surgery: a retrospective study

PURPOSE: The venous-to-arterial carbon dioxide partial pressure difference (CO(2) gap) has been reported to be a sensitive indicator of cardiac output adequacy. We aimed to assess whether the CO(2) gap can predict postoperative adverse outcomes after cardiac surgery. METHODS: A retrospective study w...

Descripción completa

Detalles Bibliográficos
Autores principales: Huette, Pierre, Beyls, Christophe, Mallat, Jihad, Martineau, Lucie, Besserve, Patricia, Haye, Guillaume, Guilbart, Mathieu, Dupont, Hervé, Guinot, Pierre-Grégoire, Diouf, Momar, Mahjoub, Yazine, Abou-Arab, Osama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785330/
https://www.ncbi.nlm.nih.gov/pubmed/33403551
http://dx.doi.org/10.1007/s12630-020-01881-4
_version_ 1783632419453140992
author Huette, Pierre
Beyls, Christophe
Mallat, Jihad
Martineau, Lucie
Besserve, Patricia
Haye, Guillaume
Guilbart, Mathieu
Dupont, Hervé
Guinot, Pierre-Grégoire
Diouf, Momar
Mahjoub, Yazine
Abou-Arab, Osama
author_facet Huette, Pierre
Beyls, Christophe
Mallat, Jihad
Martineau, Lucie
Besserve, Patricia
Haye, Guillaume
Guilbart, Mathieu
Dupont, Hervé
Guinot, Pierre-Grégoire
Diouf, Momar
Mahjoub, Yazine
Abou-Arab, Osama
author_sort Huette, Pierre
collection PubMed
description PURPOSE: The venous-to-arterial carbon dioxide partial pressure difference (CO(2) gap) has been reported to be a sensitive indicator of cardiac output adequacy. We aimed to assess whether the CO(2) gap can predict postoperative adverse outcomes after cardiac surgery. METHODS: A retrospective study was conducted of 5,151 patients from our departmental database who underwent cardiac surgery from 1 January 2008 to 31 December 2018. Lactate level (mmol·L(−1)), central venous oxygen saturation (ScVO(2)) (%), and the venous-to-arterial carbon dioxide difference (CO(2) gap) were measured at intensive care unit (ICU) admission and on days 1 and 2 after cardiac surgery. The following postoperative adverse outcomes were collected: ICU mortality, hemopericardium or tamponade, resuscitated cardiac arrest, acute kidney injury, major bleeding, acute hepatic failure, mesenteric ischemia, and pneumonia. The primary outcome was the presence of at least one postoperative adverse outcome. Logistic regression was used to assess the association between ScVO(2), lactate, and the CO(2) gap with adverse outcomes. Their diagnostic performance was compared using a receiver operating characteristic (ROC) curve. RESULTS: There were 1,933 patients (38%) with an adverse outcome. Cardiopulmonary bypass (CPB) parameters were similar between groups. The CO(2) gap was slightly higher for the “adverse outcomes” group than for the “no adverse outcomes” group. Arterial lactate at admission, day 1, and day 2 was also slightly higher in patients with adverse outcomes. Central venous oxygen saturation was not significantly different between patients with and without adverse outcomes. The area under the ROC curve to predict outcomes after CPB for the CO(2) gap at admission, day 1, and day 2 were 0.52, 0.55, and 0.53, respectively. CONCLUSION: After cardiac surgery with CPB, the CO(2) gap at ICU admission, day 1, and day 2 was associated with postoperative adverse outcomes but showed poor diagnostic performance.
format Online
Article
Text
id pubmed-7785330
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-77853302021-01-06 Central venous-to-arterial CO(2) difference is a poor tool to predict adverse outcomes after cardiac surgery: a retrospective study Huette, Pierre Beyls, Christophe Mallat, Jihad Martineau, Lucie Besserve, Patricia Haye, Guillaume Guilbart, Mathieu Dupont, Hervé Guinot, Pierre-Grégoire Diouf, Momar Mahjoub, Yazine Abou-Arab, Osama Can J Anaesth Reports of Original Investigations PURPOSE: The venous-to-arterial carbon dioxide partial pressure difference (CO(2) gap) has been reported to be a sensitive indicator of cardiac output adequacy. We aimed to assess whether the CO(2) gap can predict postoperative adverse outcomes after cardiac surgery. METHODS: A retrospective study was conducted of 5,151 patients from our departmental database who underwent cardiac surgery from 1 January 2008 to 31 December 2018. Lactate level (mmol·L(−1)), central venous oxygen saturation (ScVO(2)) (%), and the venous-to-arterial carbon dioxide difference (CO(2) gap) were measured at intensive care unit (ICU) admission and on days 1 and 2 after cardiac surgery. The following postoperative adverse outcomes were collected: ICU mortality, hemopericardium or tamponade, resuscitated cardiac arrest, acute kidney injury, major bleeding, acute hepatic failure, mesenteric ischemia, and pneumonia. The primary outcome was the presence of at least one postoperative adverse outcome. Logistic regression was used to assess the association between ScVO(2), lactate, and the CO(2) gap with adverse outcomes. Their diagnostic performance was compared using a receiver operating characteristic (ROC) curve. RESULTS: There were 1,933 patients (38%) with an adverse outcome. Cardiopulmonary bypass (CPB) parameters were similar between groups. The CO(2) gap was slightly higher for the “adverse outcomes” group than for the “no adverse outcomes” group. Arterial lactate at admission, day 1, and day 2 was also slightly higher in patients with adverse outcomes. Central venous oxygen saturation was not significantly different between patients with and without adverse outcomes. The area under the ROC curve to predict outcomes after CPB for the CO(2) gap at admission, day 1, and day 2 were 0.52, 0.55, and 0.53, respectively. CONCLUSION: After cardiac surgery with CPB, the CO(2) gap at ICU admission, day 1, and day 2 was associated with postoperative adverse outcomes but showed poor diagnostic performance. Springer International Publishing 2021-01-06 2021 /pmc/articles/PMC7785330/ /pubmed/33403551 http://dx.doi.org/10.1007/s12630-020-01881-4 Text en © Canadian Anesthesiologists' Society 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Reports of Original Investigations
Huette, Pierre
Beyls, Christophe
Mallat, Jihad
Martineau, Lucie
Besserve, Patricia
Haye, Guillaume
Guilbart, Mathieu
Dupont, Hervé
Guinot, Pierre-Grégoire
Diouf, Momar
Mahjoub, Yazine
Abou-Arab, Osama
Central venous-to-arterial CO(2) difference is a poor tool to predict adverse outcomes after cardiac surgery: a retrospective study
title Central venous-to-arterial CO(2) difference is a poor tool to predict adverse outcomes after cardiac surgery: a retrospective study
title_full Central venous-to-arterial CO(2) difference is a poor tool to predict adverse outcomes after cardiac surgery: a retrospective study
title_fullStr Central venous-to-arterial CO(2) difference is a poor tool to predict adverse outcomes after cardiac surgery: a retrospective study
title_full_unstemmed Central venous-to-arterial CO(2) difference is a poor tool to predict adverse outcomes after cardiac surgery: a retrospective study
title_short Central venous-to-arterial CO(2) difference is a poor tool to predict adverse outcomes after cardiac surgery: a retrospective study
title_sort central venous-to-arterial co(2) difference is a poor tool to predict adverse outcomes after cardiac surgery: a retrospective study
topic Reports of Original Investigations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785330/
https://www.ncbi.nlm.nih.gov/pubmed/33403551
http://dx.doi.org/10.1007/s12630-020-01881-4
work_keys_str_mv AT huettepierre centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy
AT beylschristophe centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy
AT mallatjihad centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy
AT martineaulucie centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy
AT besservepatricia centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy
AT hayeguillaume centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy
AT guilbartmathieu centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy
AT dupontherve centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy
AT guinotpierregregoire centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy
AT dioufmomar centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy
AT mahjoubyazine centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy
AT abouarabosama centralvenoustoarterialco2differenceisapoortooltopredictadverseoutcomesaftercardiacsurgeryaretrospectivestudy